Class information for:
Level 1: CALCIPOTRIOL//BETAMETHASONE DIPROPIONATE//TACALCITOL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
7111 1328 30.0 67%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
669 12548 PSORIASIS//PSORIATIC ARTHRITIS//CALCIPOTRIOL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CALCIPOTRIOL Author keyword 103 59% 9% 115
2 BETAMETHASONE DIPROPIONATE Author keyword 18 53% 2% 23
3 TACALCITOL Author keyword 17 46% 2% 27
4 SCALP PSORIASIS Author keyword 11 52% 1% 15
5 TWO COMPOUND PRODUCT Author keyword 9 83% 0% 5
6 TAZAROTENE Author keyword 6 31% 1% 17
7 DERMATOL U 905 Address 6 100% 0% 4
8 CLIN DERMAL VENEREAL DIS Address 5 63% 0% 5
9 CALCIPOTRIENE Author keyword 5 50% 1% 7
10 BAYLOR PSORIASIS Address 4 75% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CALCIPOTRIOL 103 59% 9% 115 Search CALCIPOTRIOL Search CALCIPOTRIOL
2 BETAMETHASONE DIPROPIONATE 18 53% 2% 23 Search BETAMETHASONE+DIPROPIONATE Search BETAMETHASONE+DIPROPIONATE
3 TACALCITOL 17 46% 2% 27 Search TACALCITOL Search TACALCITOL
4 SCALP PSORIASIS 11 52% 1% 15 Search SCALP+PSORIASIS Search SCALP+PSORIASIS
5 TWO COMPOUND PRODUCT 9 83% 0% 5 Search TWO+COMPOUND+PRODUCT Search TWO+COMPOUND+PRODUCT
6 TAZAROTENE 6 31% 1% 17 Search TAZAROTENE Search TAZAROTENE
7 CALCIPOTRIENE 5 50% 1% 7 Search CALCIPOTRIENE Search CALCIPOTRIENE
8 CALCIPOTRIOL BETAMETHASONE DIPROPIONATE 4 75% 0% 3 Search CALCIPOTRIOL+BETAMETHASONE+DIPROPIONATE Search CALCIPOTRIOL+BETAMETHASONE+DIPROPIONATE
9 GOECKERMAN 3 57% 0% 4 Search GOECKERMAN Search GOECKERMAN
10 1 24OH2D 3 3 100% 0% 3 Search 1+24OH2D+3 Search 1+24OH2D+3

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ONCE DAILY TREATMENT 83 76% 4% 59
2 MC 903 77 67% 5% 70
3 BETAMETHASONE DIPROPIONATE 62 60% 5% 68
4 CALCIPOTRIOL 60 43% 8% 107
5 MC 903 OINTMENT 49 79% 2% 31
6 CALCIPOTRIOL MC 903 OINTMENT 48 100% 1% 17
7 CALCIPOTRIENE OINTMENT 41 87% 2% 20
8 HALOBETASOL OINTMENT 38 86% 1% 19
9 CALCIPOTRIOL OINTMENT 38 76% 2% 26
10 CALCIPOTRIOL BETAMETHASONE DIPROPIONATE 31 92% 1% 12

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer 2015 1 26 27%
Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses 2013 11 64 84%
In touch with psoriasis: topical treatments and current guidelines 2011 24 12 83%
Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis 2014 5 32 69%
Adherence to topical treatment in psoriasis: a systematic literature review 2012 27 34 53%
Topical long-term therapy of psoriasis with vitamin D-3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice 2014 3 31 84%
New topical treatments for psoriasis 2014 8 45 38%
Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy 2012 13 26 77%
Topical preparations for the treatment of psoriasis: a systematic review 2002 78 76 79%
Calcipotriol/Betamethasone Dipropionate A Review of its Use in the Treatment of Psoriasis Vulgaris of the Trunk, Limbs and Scalp 2011 10 42 90%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DERMATOL U 905 6 100% 0.3% 4
2 CLIN DERMAL VENEREAL DIS 5 63% 0.4% 5
3 BAYLOR PSORIASIS 4 75% 0.2% 3
4 PSORIASISSTUDIENZENTRUM 3 100% 0.2% 3
5 INSERM CRO2 2 36% 0.4% 5
6 BASIL GERALD FELSENSTEIN MED 2 23% 0.6% 8
7 MARSELISBORG 2 40% 0.3% 4
8 LARCHET HOSP 2 2 26% 0.4% 5
9 MANAGEMENT COMMUNITY HLTH SCI 1 50% 0.2% 2
10 EA3181IFR133 1 33% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000236458 ANTHRALIN//DITHRANOL//ANTHRACENONE
2 0.0000181283 PSORIASIS//EFALIZUMAB//ALEFACEPT
3 0.0000179590 CHILDHOOD PSORIASIS//JUVENILE PSORIASIS//PERIANAL STREPTOCOCCAL DERMATITIS
4 0.0000174331 BATH PUVA//8 METHOXYPSORALEN//PUVA
5 0.0000146085 HUMAN SKIN BLANCHING ASSAY//SKIN BLANCHING//CLOBETASOL 17 PROPIONATE
6 0.0000119926 PIMECROLIMUS//ATOPIC DERMATITIS//TACROLIMUS OINTMENT
7 0.0000110994 PSORIASIS//TAIYUAN CITY HOSP//MOUSE TAIL TEST
8 0.0000097341 ACRODERMATITIS CONTINUA OF HALLOPEAU//VOCLOSPORIN//MICROEMULSION FORMULATION
9 0.0000068061 ED 71//ELDECALCITOL//19 NORVITAMIN D
10 0.0000060576 VITAMIN D RECEPTOR//VDR//EB1089